Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 258

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein

Open access
Martin, Catherine, Berridge, Georgina, Mistry, Prakash, Higgins, Christopher, Charlton, Peter, Callaghan, Richard·1999·British Journal of Pharmacology

Abstract

The kinetics and nature of equilibrium binding were used to characterize the molecular interaction of the anthranilic acid derivative [3 H]‐XR9576 with the multidrug resistance P‐glycoprotein (P‐gp). XR9576 displayed specific high‐affinity binding to P‐gp (B max=275 pmol mg−1, Kd=5.1 n M). The transport substrates [3 H]‐vinblastine and [3 H]‐paclitaxel displayed 4 fold and 20 fold lower affinity respectively for P‐gp. The duration of action of XR9576 with P‐gp was increased in comparison to that of vinblastine which displayed a slower rate of association and a faster dissociation rate. The relative affinities of several modulators and transport substrates to interact with P‐gp were determined from displacement drug equilibrium binding assays. Vinblastine and paclitaxel could only fractionally displace [3 H]‐XR9576 binding, displaying Ki values significantly different from their measured Kd values. This suggests a non‐competitive interaction between XR9576 and the P‐gp substrates vinblastine and paclitaxel. XR9576 was shown to be a potent modulator of P‐gp mediated [3 H]‐vinblastine and [3 H]‐paclitaxel transport as it increased the steady‐state accumulation of these cytotoxics in CH r B30 cells to levels observed in non‐P‐gp‐expressing AuxB1 cells (EC 50=487±50 n M). This inhibition of drug transport is not mediated through competition for transport since [3 H]‐XR9576 accumulation was not influenced by P‐gp expression or function. These results demonstrate that the P‐gp modulator XR9576 exhibits greater selectivity, duration of inhibition and potency of interaction with this transporter than any other reported modulators. Several lines of evidence suggest that XR9576 inhibits P‐gp function by binding at a site which is distinct from the site of interaction of transport substrates. The two sites may be classified as serving modulatory or transport functions. British Journal of Pharmacology (1999) 128, 403–411; doi:10.1038/sj.bjp.0702807

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0702807

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 258

Metadata

Authors
Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P., & Callaghan, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1999-09
Volume
128
Issue
2
Pages
403-411
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2024250662
Cited by
258
References
23
FWCI
2.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein. https://app.cochat.ai/papers/10.1038/sj.bjp.0702807
The paper
Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P., & Callaghan, R. (1999). The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0702807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.